1.77
price up icon2.91%   0.05
after-market Handel nachbörslich: 1.78 0.01 +0.56%
loading
Schlusskurs vom Vortag:
$1.72
Offen:
$1.74
24-Stunden-Volumen:
8.01M
Relative Volume:
0.87
Marktkapitalisierung:
$484.74M
Einnahmen:
$188.87M
Nettoeinkommen (Verlust:
$-400.38M
KGV:
-1.3937
EPS:
-1.27
Netto-Cashflow:
$-260.90M
1W Leistung:
-4.58%
1M Leistung:
-3.80%
6M Leistung:
-3.28%
1J Leistung:
-78.62%
1-Tages-Spanne:
Value
$1.695
$1.84
1-Wochen-Bereich:
Value
$1.49
$1.88
52-Wochen-Spanne:
Value
$1.16
$10.65

Pacific Biosciences Of California Inc Stock (PACB) Company Profile

Name
Firmenname
Pacific Biosciences Of California Inc
Name
Telefon
650-521-8000
Name
Adresse
1305 O'BRIEN DRIVE, MENLO PARK, CA
Name
Mitarbeiter
796
Name
Twitter
@pacbio
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
PACB's Discussions on Twitter

Vergleichen Sie PACB mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
PACB 1.77 484.74M 188.87M -400.38M -260.90M -1.27
ABT 117.26 201.11B 41.22B 5.77B 6.49B 2.94
SYK 390.14 148.40B 21.97B 3.59B 3.21B 6.74
BSX 91.50 134.72B 15.91B 1.79B 1.89B 0.82
MDT 84.74 108.57B 33.00B 4.29B 5.50B 2.71
EW 70.38 41.51B 6.60B 4.16B 490.10M 2.34

Pacific Biosciences Of California Inc Stock (PACB) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-12-14 Eingeleitet Guggenheim Neutral
2023-12-14 Eingeleitet Stephens Overweight
2023-12-13 Eingeleitet Wolfe Research Peer Perform
2023-11-17 Hochstufung UBS Neutral → Buy
2023-10-31 Hochstufung Cantor Fitzgerald Neutral → Overweight
2023-09-28 Eingeleitet Bernstein Outperform
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-06-30 Eingeleitet Goldman Buy
2023-05-10 Eingeleitet Barclays Equal Weight
2023-03-31 Hochstufung TD Cowen Market Perform → Outperform
2023-02-02 Eingeleitet UBS Neutral
2023-01-20 Herabstufung Cantor Fitzgerald Overweight → Neutral
2023-01-05 Eingeleitet Scotiabank Sector Outperform
2022-01-21 Fortgesetzt Cantor Fitzgerald Overweight
2022-01-06 Fortgesetzt Piper Sandler Neutral
2021-10-15 Fortgesetzt Cowen Market Perform
2021-09-27 Eingeleitet Canaccord Genuity Buy
2021-02-11 Hochstufung Piper Sandler Neutral → Overweight
2020-11-03 Herabstufung Piper Sandler Overweight → Neutral
2020-10-02 Hochstufung JP Morgan Neutral → Overweight
2020-09-09 Eingeleitet Morgan Stanley Equal-Weight
2020-06-02 Fortgesetzt Cantor Fitzgerald Overweight
2020-03-09 Fortgesetzt Cantor Fitzgerald Overweight
2019-10-15 Hochstufung Piper Jaffray Neutral → Overweight
2019-04-02 Herabstufung Stephens Overweight → Equal-Weight
2018-10-19 Eingeleitet Cowen Outperform
2017-11-03 Herabstufung First Analysis Sec Overweight → Equal-Weight
2017-09-28 Herabstufung CL King Buy → Neutral
2016-11-03 Bestätigt Cantor Fitzgerald Buy
2016-06-27 Eingeleitet CL King Buy
2016-04-15 Eingeleitet First Analysis Sec Overweight
2016-02-04 Herabstufung Piper Jaffray Overweight → Neutral
2016-01-04 Bestätigt Cantor Fitzgerald Buy
2015-10-23 Hochstufung Piper Jaffray Neutral → Overweight
2015-08-27 Eingeleitet Cantor Fitzgerald Buy
2015-02-04 Bestätigt Maxim Group Buy
2013-09-26 Bestätigt Maxim Group Buy
2013-01-14 Bestätigt Maxim Group Buy
Alle ansehen

Pacific Biosciences Of California Inc Aktie (PACB) Neueste Nachrichten

pulisher
Nov 20, 2024

PACB Stock Falls Despite Q3 Earnings Beat, Revenues Decline Y/Y - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Pacific Biosciences of California, Inc. (PACB): Among the Best Genomics Stocks to Buy Right Now - Insider Monkey

Nov 19, 2024
pulisher
Nov 19, 2024

10 Best Genomics Stocks To Buy Right Now - Insider Monkey

Nov 19, 2024
pulisher
Nov 18, 2024

Sumitomo Mitsui Trust Group Inc. Has $20.17 Million Stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB) - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Research Analysts Offer Predictions for PACB FY2024 Earnings - MarketBeat

Nov 18, 2024
pulisher
Nov 14, 2024

DNA Sequencing Market to Grow by USD 17.34 Billion (2024-2028), Driven by Rising NGS Adoption, AI-Powered Report Explores Market EvolutionTechnavio - The Malaysian Reserve

Nov 14, 2024
pulisher
Nov 14, 2024

Pacific Biosciences of California (NASDAQ:PACB) Upgraded by UBS Group to "Hold" Rating - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Pacific Biosciences CCO departs amid restructuring By Investing.com - Investing.com Australia

Nov 13, 2024
pulisher
Nov 13, 2024

Pacific Biosciences CCO departs amid restructuring - Investing.com India

Nov 13, 2024
pulisher
Nov 12, 2024

Pacific Biosciences' Cost Cuts Won't Offset Rising Competition (NASDAQ:PACB) - Seeking Alpha

Nov 12, 2024
pulisher
Nov 12, 2024

Pacific Biosciences of California Inc (PACB) Quarterly 10-Q Report - Quartzy

Nov 12, 2024
pulisher
Nov 12, 2024

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Motley Fool

Nov 12, 2024
pulisher
Nov 12, 2024

Pacific Biosciences of California (NASDAQ:PACB) Trading Up 5.3% Following Analyst Upgrade - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Pacific Biosciences of California Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 12, 2024
pulisher
Nov 12, 2024

UBS Downgrades Pacific Biosciences of California (PACB) - MSN

Nov 12, 2024
pulisher
Nov 11, 2024

Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates - MSN

Nov 11, 2024
pulisher
Nov 11, 2024

Cathie Wood's ARK sells Unity, buys Pacific Biosciences stock By Investing.com - Investing.com Nigeria

Nov 11, 2024
pulisher
Nov 11, 2024

Cathie Wood's ARK sells Unity, buys Pacific Biosciences stock - Investing.com

Nov 11, 2024
pulisher
Nov 11, 2024

PacBio’s $459 Million Convertible Note Exchange Offering - Global Legal Chronicle

Nov 11, 2024
pulisher
Nov 11, 2024

Scotiabank Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $6.00 - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Pacific Biosciences of California Target of Unusually High Options Trading (NASDAQ:PACB) - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Pacific Biosciences of California (NASDAQ:PACB) Rating Lowered to "Neutral" at UBS Group - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Pacific Biosciences of California (NASDAQ:PACB) Price Target Raised to $2.50 - MarketBeat

Nov 11, 2024
pulisher
Nov 09, 2024

Earnings Update: Pacific Biosciences of California, Inc. (NASDAQ:PACB) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts - Yahoo Finance

Nov 09, 2024
pulisher
Nov 09, 2024

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024
pulisher
Nov 09, 2024

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Nov 09, 2024
pulisher
Nov 08, 2024

Wilson Sonsini Advises PacBio on $459 Million Convertible Note Exchange - Wilson Sonsini

Nov 08, 2024
pulisher
Nov 08, 2024

PacBio to Present at 4 Major Healthcare Investor Conferences Through Year-End | PACB Stock News - StockTitan

Nov 08, 2024
pulisher
Nov 08, 2024

Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings Ca - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

Pacific Biosciences of California (NASDAQ:PACB) Shares Gap DownShould You Sell? - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings Call Highlights: Navigating ... By GuruFocus - Investing.com Canada

Nov 08, 2024
pulisher
Nov 08, 2024

Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings Call Highlights: Navigating ... - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

Pacific Biosciences: Q3 Earnings Snapshot - CTPost

Nov 08, 2024
pulisher
Nov 08, 2024

Pacific Biosciences of California (FRA:P09) 5-Day RSI : 64.86 (As of Nov. 08, 2024) - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

PacBio stock falls 16% post-market after Q3 revenue miss - MSN

Nov 08, 2024
pulisher
Nov 07, 2024

Pacific Biosciences of California, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings: E - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

PacBio Announces Third Quarter 2024 Financial Results - GlobeNewswire

Nov 07, 2024
pulisher
Nov 07, 2024

PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028 - StockTitan

Nov 07, 2024
pulisher
Nov 07, 2024

Strong week for Pacific Biosciences of California (NASDAQ:PACB) shareholders doesn't alleviate pain of three-year loss - Simply Wall St

Nov 07, 2024
pulisher
Nov 07, 2024

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Stock Rockets 56% But Many Are Still Ignoring The Company - Simply Wall St

Nov 07, 2024
pulisher
Nov 06, 2024

PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop - StockTitan

Nov 06, 2024
pulisher
Nov 06, 2024

Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings Re - GuruFocus.com

Nov 06, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Reduction in Pacific Biosciences of California Inc - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

Reasons to Retain PacBio Stock in Your Portfolio for Now - MSN

Nov 04, 2024
pulisher
Nov 04, 2024

Curious about Pacific Biosciences (PACB) Q3 Performance? Explore Wall Street Estimates for Key Metrics - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Sold by Assenagon Asset Management S.A. - MarketBeat

Nov 04, 2024
pulisher
Oct 31, 2024

Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Pacific Biosciences of California (PACB) Scheduled to Post Earnings on Thursday - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

Pacific Biosciences (PACB): Promising Gene Editing Stock With Innovating Technology - Insider Monkey

Oct 30, 2024

Finanzdaten der Pacific Biosciences Of California Inc-Aktie (PACB)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices STE
$215.77
price up icon 1.66%
medical_devices ZBH
$108.40
price down icon 0.80%
medical_devices PHG
$26.38
price up icon 0.27%
$74.46
price down icon 1.04%
$82.00
price down icon 3.42%
medical_devices EW
$70.38
price up icon 1.21%
Kapitalisierung:     |  Volumen (24h):